Contact
Please use this form to send email to PR contact of this press release:
ONL Therapeutics Raises $3 Million in a Convertible Note to Advance ONL1204 into First-In-Human Clinical Study
TO:
Please use this form to send email to PR contact of this press release:
ONL Therapeutics Raises $3 Million in a Convertible Note to Advance ONL1204 into First-In-Human Clinical Study
TO: